Position in NVCR
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$2,396,320
+$2,089,703 QoQ
Shares Held
158,173
+462.3% QoQ
Ownership
0.136%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#59
of 217 holders
Holding Since
Jun 2020
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVCR Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026ARROWSTREET CAPITAL, LIMITED PARTNERSHIP holds $6,436,102,900 across 46 Medical Devices names. NVCR ranks #35 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SYK |
Stryker Corp
|
3,282,207 | $1,033,370,051 | |
| 2 | MDT |
Medtronic plc
|
12,892,710 | $1,008,596,703 | |
| 3 | BSX |
Boston Scientific Corp
|
23,293,913 | $994,184,206 | |
| 4 | ABT |
Abbott Laboratories
|
10,897,178 | $988,809,931 | |
| 5 | EW |
Edwards Lifesciences Corp
|
5,677,344 | $513,572,538 | |
| 6 | DXCM |
Dexcom Inc
|
6,873,273 | $462,914,936 | |
| 7 | PEN |
Penumbra Inc
|
834,903 | $263,620,622 | |
| 8 | STE |
STERIS plc
|
1,217,864 | $256,445,622 |
All Filings in NVCR
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,396,320 | 158,173 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $306,617 | 28,130 | Shares | Defined | 2026-05-14 | |
| 2022-06-30 | $2,118,568 | 30,483 | Shares | Defined | 2022-08-15 | |
| 2020-06-30 | $379,520 | 6,400 | Shares | Defined | 2020-08-12 | |
| No filing history on record for this holder in this stock. | ||||||